Current Report Filing (8-k)
09 5월 2020 - 5:37AM
Edgar (US Regulatory)
0001055160
false
0001055160
2020-05-05
2020-05-06
0001055160
us-gaap:CommonStockMember
2020-05-05
2020-05-06
0001055160
us-gaap:SeriesBPreferredStockMember
2020-05-05
2020-05-06
0001055160
us-gaap:SeriesCPreferredStockMember
2020-05-05
2020-05-06
0001055160
MFA:SeniorNotesDue2042Member
2020-05-05
2020-05-06
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event
reported): May 6, 2020
MFA Financial, Inc.
(Exact name of Registrant as specified
in its charter)
Maryland
|
|
1-13991
|
|
13-3974868
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification No.)
|
350 Park Avenue, 20th floor
New York, New York 10022
(Address of principal executive offices)
Registrant's
telephone number, including area code: (212) 207-6400
Not Applicable
(Former Name or Address, if Changed Since
Last Report)
Check the appropriate box below if the Form 8-K is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
|
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)
|
Securities registered pursuant to Section 12(b) of the Act:
Title
of each class:
|
|
Trading
Symbols:
|
|
Name
of each exchange
on which registered:
|
Common
Stock, par value $0.01 per share
|
|
MFA
|
|
New
York Stock Exchange
|
7.50%
Series B Cumulative Redeemable Preferred Stock, par value $0.01 per share
|
|
MFA/PB
|
|
New
York Stock Exchange
|
6.50% Series C Fixed-to-Floating Rate
Cumulative Redeemable Preferred Stock, par value $0.01 per share
|
|
MFA/PC
|
|
New York Stock Exchange
|
8.00%
Senior Notes due 2042
|
|
MFO
|
|
New
York Stock Exchange
|
Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ¨
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
|
Item 5.02
|
Departure of Directors or Certain Officers; Election
of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
|
(e) On May 6, 2020, MFA Financial, Inc.
(“MFA” or the “Company”) entered into an agreement (the “Agreement”) with Stephen D. Yarad,
Chief Financial Officer of the Company, regarding the payment of severance and other benefits to Mr.
Yarad in circumstances where his employment is terminated by MFA without Cause (as such term is defined in the Agreement) or he
resigns for Good Reason (as such term is defined in the Agreement). The Agreement generally provides for severance protection
under these circumstances that is consistent with the severance protection provided to the Company’s other most highly compensated
senior executives. More specifically, in such circumstances, subject to Mr. Yarad’s execution of a release of claims against
MFA and its affiliates, Mr. Yarad will be entitled to the following:
(i) aggregate
cash equal to the sum of (A) his annual base salary and (B) the average of the
annual bonuses received by Mr. Yarad for the three (3) preceding years, which will be payable to him in a lump sum
not later than 60 days following the date of termination of employment; and
(ii) immediate
vesting of all outstanding unvested time-based equity awards; and
(iii)
immediate vesting in a pro-rata portion of the target value of any unvested performance-based equity awards. The pro-rata
portion shall be equal to the product of (a) the target value of such award, and (b) a fraction, the numerator of which is the
number of days during the performance period that would have elapsed as of the anniversary of the date of grant of such award next
following the date of termination of employment (but not beyond the end of the applicable performance period), and the denominator
of which is the number of days in the performance period; and
(iv)
reimbursement for 100% of the COBRA premiums incurred by Mr. Yarad for himself and his eligible dependents under the Company’s
health care plan during the 12-month period following the date of termination of employment; and
(v) any
accrued but unpaid base salary and any other amounts earned, accrued or owing but not yet paid to Mr. Yarad and any other benefits
in accordance with the terms of any applicable plans and programs of the Company.
The
Agreement has a fixed term that expires on December 31, 2021. In addition, the Agreement provides that if any payments or
benefits provided to Mr. Yarad would constitute excess parachute payments within the meaning of Section 280G of the Internal
Revenue Code of 1986, as amended (the “Code”), and would be subject to the excise tax imposed under Section 4999
of the Code, the payments or benefits will be reduced by the amount required to avoid the excise tax, if such reduction would give
Mr. Yarad a better after-tax result than if he received the full payments and benefits and paid the excise tax.
The
Agreement also contains customary confidentiality and non-solicitation covenants, as well as other terms customary for agreements
applicable to senior executives.
*****
A
copy of the Agreement is attached hereto as Exhibit 10.1. The above description of the principal terms of the Agreement
is a summary only and is qualified in its entirety by reference to the exhibit, which is incorporated by reference into this Item
5.02.
Item 9.01 Financial
Statements and Exhibits
(d) Exhibits
104
|
Cover Page Interactive Data File (formatted as Inline
XBRL)
|
EXHIBIT INDEX
104
|
Cover Page Interactive Data File (formatted as Inline
XBRL).
|
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: May 8, 2020
|
MFA FINANCIAL, INC.
|
|
|
|
By:
|
/s/ Harold E. Schwartz
|
|
|
Harold E. Schwartz
|
|
|
Senior Vice President and General Counsel
|
MFA Financial (NYSE:MFO)
과거 데이터 주식 차트
부터 1월(1) 2025 으로 2월(2) 2025
MFA Financial (NYSE:MFO)
과거 데이터 주식 차트
부터 2월(2) 2024 으로 2월(2) 2025